ImageneBio, Inc. IMA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.48M | -49.89M | -45.35M | -43.25M | -- |
| Total Depreciation and Amortization | 1.22M | 1.13M | 1.03M | 566.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.99M | 16.35M | 15.66M | 15.63M | -- |
| Change in Net Operating Assets | -18.31M | -23.00M | -19.19M | -17.05M | -- |
| Cash from Operations | -52.59M | -55.41M | -47.84M | -44.10M | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 103.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -5.22M | -5.22M | -5.22M | -5.22M | -- |
| Other Investing Activities | -1.39M | -1.04M | -599.00K | 765.00K | -- |
| Cash from Investing | -6.60M | -6.25M | -5.81M | -4.35M | -- |
| Total Debt Issued | 0.00 | 15.00M | 15.00M | 22.50M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 71.17M | 71.17M | 71.18M | 71.18M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 76.06M | 46.03M | 49.29M | 48.70M | -- |
| Cash from Financing | 147.23M | 132.20M | 135.47M | 142.37M | -- |
| Foreign Exchange rate Adjustments | 614.00K | 601.00K | 604.00K | 622.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.66M | 71.13M | 82.41M | 94.55M | -- |